Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
about
Clinical improvement induced by rituximab in two cases of type II mixed cryoglobulinaemia syndrome unresponsive to conventional treatments.An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia.Hepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionHepatitis C virus-induced cryoglobulinemia.
P2860
Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Should rituximab be the rescue ...... a associated with hepatitis C?
@en
type
label
Should rituximab be the rescue ...... a associated with hepatitis C?
@en
prefLabel
Should rituximab be the rescue ...... a associated with hepatitis C?
@en
P1476
Should rituximab be the rescue ...... a associated with hepatitis C?
@en
P2093
Christopher F Wong
Muhammad S Ahmed
P304
P577
2007-05-01T00:00:00Z